Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation

Hematology/Oncology Clinics of North America

Volumn 14, Issue 2, 2000, Pages 445-457

  Kawada, Tadanori ^a   Kitagawa, Hiroaki ^d   Hoson, Masayuki ^e   Okada, Yoshiharu ^b   Shiomura, Jin ^c  

^a Shizuoka Medical Center   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Mitsubishi Tokyo Pharmaceuticals Inc ^*  (Japan)

^d Divisions of Pediatric Surgery

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; ARGATROBAN; BETA THROMBOGLOBULIN; FIBRIN MONOMER; FIBRINOGEN; FIBRINOPEPTIDE A; HEPARIN; HIRUDIN; THROMBOCYTE FACTOR 4;

ANTICOAGULANT THERAPY; BLOOD CLOTTING TIME; BLOOD PUMP; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEPARINIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 0034091906     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70144-1     Document Type: Article

References (42)

1. Anderson H.L. III R.J. Attorri J.R. Custer Extracorporeal membrane oxygenation for pediatric cardiopulmonary failure J Thorac Cardiovasc Surg 99 1990 1011
2. T.L. Bauer G. Arepally B.A. Konkle Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242
3. W. Dietrich M. Spannagl W. Schramm The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass J Thorac Cardiovasc Surg 102 1991 505
4. S. Endo T. Kawada M. Hoson Usefulness of argatroban, an antithrombin agent, in experimental short-term cardiopulmonary bypass using a membrane oxygenator and a centrifugal pump Japanese Journal of Artificial Organs 26 1997 641
5. J.W. Fenton F.A. Ofosu D.V. Brezniak Thrombin and antithrombotics Semin Thromb Hemost 24 1998 87
6. B. Frenckner H. Ehren K. Palmer Surface-heparinized neonatal ECMO circuit: An experimental animal study Perfusion 7 1992 47
7. K. Fukutake M. Tateyama K. Amano Clinical pharmacology of argatroban, selective anti-thrombin agent: Comparative study with heparin Cardioangiology (Japanese) 29 1991 190
8. G.P. Gravlee W.S. Haddon H.K. Rothberger Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation J Thorac Cardiovasc Surg 99 1990 518
9. H. Hara Y. Tamao R. Kikumoto Effect of argipidine (MD 805) on platelet function Japanese Pharmacological Therapy 14 1986 13
10. G.E. Hardart J.C. Fackler Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation J Pediatr 134 1999 156
11. J.P.R. Hermann M.J.B. Kutryk P.W. Serruys Clinical trials of direct thrombin inhibitors during invasive procedures Thromb Haemost 78 1997 367
12. F. Horkay P. Martin S.M. Rajah Response to heparinization in adults and children undergoing cardiac operations Ann Thorac Surg 53 1992 822
13. T. Kawada T. Mieda M. Hoson Left heart bypass with the Bio-Meidicus centrifugal pump: The use of argatroban for preventing platelet loss Artificial Organs Today 2 1992 177
14. T. Kawada Y. Okada M. Hoson Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture Journal of the Japanese Association for Thoracic Surgery 47 1999 104
15. J. Lefkovits E.J. Topol Direct thrombin inhibitors in cardiovascular medicine Circulation 90 1994 1522
16. Magovern G.J. Jr J.A. Magovern D.H. Benckart Extracorporeal membrane oxygenation: Preliminary results in patients with postcardiotomy cardiogenic shock Ann Thorac Surg 57 1994 1462
17. H. Matsukura S. Uzawa H. Takeda Experimental extracorporeal circulation with a synthetic antithrombin agent, MD 805, without heparin Journal of the Japanese Association for Thoracic Surgery 31 1983 1377
18. T. Matsuo S. Yamada K. Nakao Effect of a new synthetic anticoagulant (MD 805) on platelet Japanese Journal of Hematology 50 1987 654
19. T. Matsuo M. Koide K. Kario Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation Artif Organs 21 1997 1035
20. R. Matsuwaka H. Matsuda M. Kaneko Experimental evaluation of a heparin coated ECMO system simplified with a centrifugal pump Transactions of the American Society For Artificial Internal Organs 36 1990 M473
21. N. Mitsui T. Koyama A. Marui Experience with emergency cardiac surgery following institution of percutaneous cardiopulmonary support Artif Organs 23 1999 496
22. M.R. Mooney K.V. Arom L.D. Joyce Emergency cardiopulmonary bypass support in patients with cardiac arrest J Thorac Cardiovasc Surg 101 1991 450
23. K. Mottaghy B. Oedekoven K. Poppel Heparin free long-term extracorporeal circulation using bioactive surfaces Transactions of the American Society For Artificial Internal Organs 35 1989 635
24. Y. Okada T. Kawada S. Endo Use of an antithrombin agent, argatroban, in percutaneous cardiopulmonary support (PCPS) for patients undergoing cardiovascular surgery Japanese Journal of Artificial Organs 27 1998 394
25. Y. Okada T. Kawada M. Hoson Clinical application of argatroban as an anticoagulant for PCPS: Its advantages in reducing the risk of bleeding as determined by hemostatic molecular markers Japanese Journal of Artificial Organs 28 1999 412
26. S. Okamoto A. Hijikata R. Kikumoto Potent inhibition of thrombin by the newly synthesized arginine derivative, No 805: The importance of stereostructure of its hydrophobic carboxamide portion Biochem Biophys Res Commun 101 1981 440
27. T.L. Ortel B.H. Chong New treatment options for heparin-induced thrombocytopenia Semin Hematol 35 1998 26
28. S.J. Phillips B. Ballentine D. Slonine Percutaneous initiation of cardiopulmonary bypass Ann Thorac Surg 36 1983 223
29. S.J. Phillips R.H. Zeff C. Kongtahworn Percutaneous cardiopulmonary bypass: Application and indication for use Ann Thorac Surg 47 1989 121
30. R.T. Reichman C.I. Joyo W.P. Dembitsky Improved patient survival after cardiac arrest using a cardiopulmonary support system Ann Thorac Surg 49 1990 101
31. M. Sakai H. Ohteki Y. Narita Argatroban as a potential anticoagulant in cardiopulmonary bypass studies in a dog model Cardiovasc Surg 7 1999 187
32. S. Sasaki K. Yasuda Y. Matsui Therapeutic strategy of perioperative use of percutaneous cardiopulmonary bypass support (PCPS) for adult cardiac surgery Journal of the Japanese Association for Thoracic Surgery 47 1999 20
33. J.M. Sinard R.H. Bartlett Extracorporeal membrane oxygenation (ECMO): Prolonged bedside cardiopulmonary bypass Perfusion 5 1990 239
34. R.L. Swank The screen filtration pressure method in platelet research. Significance and interpretation Ser Hematol 1 1968 146
35. H. Takano Y. Miyamoto M. Kaneko Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit Journal of the Japanese Association for Thoracic Surgery 41 1993 2166
36. von Segesser L.K. M. Turina Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators J Thorac Cardiovasc Surg 98 1989 386
37. von Segesser L.K. B.M. Weiss M. Pasic Risk and benefit of low systemic heparinization during open heart operations Ann Thorac Surg 58 1994 391
38. J.M. Walenga A.R. Fasanella O. Iqbal Coagulation laboratory testing in patients treated with argatroban Semin Thromb Hemostas 25 1999 61
39. J.M. Walenga Glycosaminoglycans and the new antithrombotic drugs Biomedical Progress 12 1999 13
40. J.T. Walls J.J. Curtis D. Silver Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition Ann Thorac Surg 54 1992 787
41. T.R. Weber B. Kountzman Extracorporeal membrane oxygenation for nonneonatal pulmonary and multiple-organ failure J Pediatr Surg 33 1998 1605
42. J.A. Young C.T. Kisker D.B. Doty Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer Ann Thorac Surg 26 1978 231